Esperion Therapeutics Inc. (ESPR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Esperion Therapeutics Inc...

    NASDAQ: ESPR · Real-Time Price · USD
    3.30
    0.40 (13.79%)
    At close: Oct 03, 2025, 3:59 PM

    Esperion Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 144.76M 82.25M 124.78M 208.89M
    Short-Term Investments
    		 n/a n/a 42.09M 50.44M
    Long-Term Investments
    		 n/a n/a 42.09M 50.44M
    Other Long-Term Assets
    		 n/a n/a -42.09M 50M
    Receivables
    		 80.14M 48.49M 33.73M 22.93M
    Inventory
    		 94.49M 65.62M 35.2M 34.39M
    Other Current Assets
    		 18.02M 4.51M 9.87M n/a
    Total Current Assets
    		 338M 201.06M 246.68M 328.97M
    Property-Plant & Equipment
    		 5.77M 4.67M 1.2M 2.56M
    Goodwill & Intangibles
    		 56K 56K 56K 56K
    Total Long-Term Assets
    		 5.82M 4.73M 1.26M 52.62M
    Total Assets
    		 343.82M 205.8M 247.94M 381.59M
    Account Payables
    		 51.65M 31.72M 23.04M 17.56M
    Deferred Revenue
    		 8.52M 25.4M 3.51M 5.68M
    Short-Term Debt
    		 102.16M 34.83M 24.76M 11.29M
    Other Current Liabilities
    		 12.74M 49.24M 29.02M 24.7M
    Total Current Liabilities
    		 246.23M 156.22M 92.31M 73.35M
    Long-Term Debt
    		 483.74M 501.55M 259.9M 258.28M
    Other Long-Term Liabilities
    		 n/a n/a 218.84M 245.74M
    Total Long-Term Liabilities
    		 486.31M 504.57M 479.41M 505.18M
    Total Liabilities
    		 732.54M 660.79M 571.72M 578.53M
    Total Debt
    		 591.21M 540.95M 260.95M 260.2M
    Book Value
    		 -388.72M -454.99M -323.78M -196.94M
    Book Value Per Share
    		 -2.08 -4.41 -4.88 -6.81
    Common Stock
    		 196K 118K 75K 61K
    Retained Earnings
    		 -1.6B -1.55B -1.34B -1.11B
    Comprehensive Income
    		 n/a n/a -2K -31K
    Shareholders Equity
    		 -388.72M -454.99M -1.34B -1.11B
    Total Investments
    		 n/a n/a 84.17M 100.88M

    Add to Watchlist